Share
Our flagship daily news show, where we talk to in-house experts about what is going on and why you need to care about it.
…
continue reading
Manage episode 520459915 series 2922784
Content provided by The Globe and Mail and The Globe. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Globe and Mail and The Globe or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
For cancer patients, every day of treatment is critical. But the best care possible is not always reaching patients quickly. Despite Health Canada approving a drug treating an aggressive blood cancer, a complex web of organizations, insurance plans and negotiations over drug pricing means it’s still not available in Canada.
Globe reporters Kelly Grant, who covers health, and Chris Hannay, who covers the business of health care, tell us what is holding up life-changing drugs and why Canadian patients are the ones left with the consequences.
Questions? Comments? Ideas? Email us at [email protected]
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
1155 episodes
))
